| Identification of a novel coronavirus in patients with severe acute respiratory syndrome C Drosten, S Günther, W Preiser, S Van Der Werf, HR Brodt, S Becker, ... New England journal of medicine 348 (20), 1967-1976, 2003 | 6513 | 2003 |
| Clinical and virological data of the first cases of COVID-19 in Europe: a case series FX Lescure, L Bouadma, D Nguyen, M Parisey, PH Wicky, S Behillil, ... The Lancet Infectious Diseases 20 (6), 697-706, 2020 | 1354 | 2020 |
| Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome T Kuiken, RAM Fouchier, M Schutten, GF Rimmelzwaan, ... The Lancet 362 (9380), 263-270, 2003 | 1318 | 2003 |
| Primary structure, gene organization and polypeptide expression of poliovirus RNA N Kitamura, BL Semler, PG Rothberg, GR Larsen, CJ Adler, AJ Dorner, ... Nature 291 (5816), 547-553, 1981 | 1108 | 1981 |
| Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies D Planas, T Bruel, L Grzelak, F Guivel-Benhassine, I Staropoli, F Porrot, ... Nature medicine 27 (5), 917-924, 2021 | 742 | 2021 |
| First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020 G Spiteri, J Fielding, M Diercke, C Campese, V Enouf, A Gaymard, A Bella, ... Eurosurveillance 25 (9), 2000178, 2020 | 724 | 2020 |
| Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission B Guery, J Poissy, L El Mansouf, C Séjourné, N Ettahar, X Lemaire, ... The Lancet 381 (9885), 2265-2272, 2013 | 547 | 2013 |
| Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007–08 season A Meijer, A Lackenby, O Hungnes, B Lina, S van Der Werf, B Schweiger, ... Emerging infectious diseases 15 (4), 552, 2009 | 497 | 2009 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 476 | 2021 |
| Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility S Cauchemez, C Fraser, MD Van Kerkhove, CA Donnelly, S Riley, ... The Lancet infectious diseases 14 (1), 50-56, 2014 | 449 | 2014 |
| Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. S Van Der Werf, J Bradley, E Wimmer, FW Studier, JJ Dunn Proceedings of the National Academy of Sciences 83 (8), 2330-2334, 1986 | 442 | 1986 |
| Syncytia formation by SARS‐CoV‐2‐infected cells J Buchrieser, J Dufloo, M Hubert, B Monel, D Planas, MM Rajah, ... The EMBO journal 39 (23), e106267, 2020 | 407 | 2020 |
| Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates P Maisonnasse, J Guedj, V Contreras, S Behillil, C Solas, R Marlin, ... Nature 585 (7826), 584-587, 2020 | 386 | 2020 |
| Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E B Nal, C Chan, F Kien, L Siu, J Tse, K Chu, J Kam, I Staropoli, ... Journal of general virology 86 (5), 1423-1434, 2005 | 358 | 2005 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 355 | 2021 |
| Bat coronaviruses related to SARS-CoV-2 and infectious for human cells S Temmam, K Vongphayloth, E Baquero, S Munier, M Bonomi, ... Nature 604 (7905), 330-336, 2022 | 353 | 2022 |
| Monitoring approaches for health-care workers during the COVID-19 pandemic JA Bielicki, X Duval, N Gobat, H Goossens, M Koopmans, E Tacconelli, ... The Lancet infectious diseases 20 (10), e261-e267, 2020 | 352 | 2020 |
| Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses P Massin, S van der Werf, N Naffakh Journal of virology 75 (11), 5398-5404, 2001 | 350 | 2001 |
| A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials T Boge, M Rémigy, S Vaudaine, J Tanguy, R Bourdet-Sicard, ... Vaccine 27 (41), 5677-5684, 2009 | 283 | 2009 |
| Host restriction of avian influenza viruses at the level of the ribonucleoproteins N Naffakh, A Tomoiu, MA Rameix-Welti, S van der Werf Annu. Rev. Microbiol. 62 (1), 403-424, 2008 | 267 | 2008 |
